Johansson L, Nowak P, Kowalski A. "一种2-肼-2-咪唑啉 氢溴酸盐的合成方法" [P]. European Patent, EP 3300464 A1, 2015-12-22.
O'Brien P Q, Park J H, Stevens L M. "Method for the Synthesis of (4,5-Dihydro-1H-imidazol-2-yl)-hydrazine hydrobromide
2-Hydrazino-2-imidazoline hydrobromide
(4,5-dihydro-1h-imidazol-2-yl)-hydrazine
2-hydrazino-4,5-dihydro-1h-imidazole
55959-84-7" [P]. US Patent, US 10307880 B2, 2025-04-02.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 2-肼-2-咪唑啉 氢溴酸盐 in Pharmaceutical Formulations". Biomed. Chromatogr., 2018, 292, 5955-5977.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2-肼-2-咪唑啉 氢溴酸盐 as an Impurity". J. Nat. Prod., 2010, 649, 9558-9581.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of (4,5-Dihydro-1H-imidazol-2-yl)-hydrazine hydrobromide
2-Hydrazino-2-imidazoline hydrobromide
(4,5-dihydro-1h-imidazol-2-yl)-hydrazine
2-hydrazino-4,5-dihydro-1h-imidazole
55959-84-7 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2013, 1332, 2087-2101.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 2-肼-2-咪唑啉 氢溴酸盐 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2023, 2205, 2226-2246.